Physician profile
James E Rotolo
NPI 1588635916
$2,086.88
in general payments reported to CMS, 2019-2025
19 companies · $124 in 2025
The $124 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $508 · 2020: $155 · 2021: $341 · 2022: $498 · 2023: $329 · 2024: $132 · 2025: $124.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $585.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $558.14 | 2019-2023 | Xtandi, Myrbetriq |
| Pfizer INC. | $451.82 | 2019-2024 | |
| Janssen Biotech, INC. | $229.50 | 2019-2025 | Erleada |
| Tolmar, INC. | $117.29 | 2023-2025 | Eligard |
| Myovant Sciences INC. | $106.40 | 2021-2022 | |
| Medtronic USA, INC. | $106.35 | 2019 | |
| Medtronic, INC. | $92.09 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $91.21 | 2019-2025 | |
| Abbvie INC. | $87.44 | 2022-2025 | Botox |
| 180 Medical, INC. | $51.84 | 2022-2024 | |
| Tolmar Pharmaceuticals, INC. | $39.73 | 2019-2020 | |
| Baxter Healthcare | $31.99 | 2020 | |
| Boston Scientific Corporation | $31.81 | 2019-2025 | Ams 700 |
| Myriad Genetic Laboratories, INC. | $24.60 | 2022 | |
| Urogen Pharma, INC. | $15.71 | 2023 | Jelmyto |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.20 | 2023 | Keytruda, Lynparza |
| Dentsply Ih INC. | $12.99 | 2020 | |
| Sumitomo Pharma America, INC. | $12.92 | 2023 | Orgovyx |
| Genzyme Corporation | $11.85 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Rotolo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.